If approved, the drug will be the first new treatment for uncomplicated urinary tract infections in more than 2 decades. GSK has stopped two phase 3 clinical trials for gepotidacin, a potential new ...

While more common in females, urinary tract infections can also affect males. Symptoms include a sudden urge to urinate, frequent urination, and a burning sensation when you urinate. UTIs occur when ...

Urinary tract infections are both very common and potentially very dangerous. Around 80 per cent of UTIs are caused by uropathogenic E. coli (UPEC), which is increasingly resistant to antibiotics. E.

Yeast infections and UTIs are uncomfortable in their own ways. While yeast infections often trigger itching, burning, and redness, UTIs are usually accompanied by pain and the frequent urge to urinate ...

Bacteria entering the urinary tract is the most common cause of a UTI. Most UTIs that affect the lower urinary tract are caused by E. coli, as well as other types of bacteria that are normally found ...

LAS VEGAS, July 5, 2021 /PRNewswire/ -- DelveInsight's Uncomplicated Urinary Tract Infection (uUTI) Market report offers a comprehensive coverage of the current treatment practices, pipeline drugs, ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Urinary Tract Infection Treatment Market, Forecast by Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, ...

In January 2025, Wockhardt announced that ZAYNICH demonstrated unprecedented efficacy in a global, pivotal Phase III study ...